Lipogems
-
Financial
Lipogems Raises €12.5M ($13.2M) to Accelerate the Expansion in Knee Osteoarthritis
ATLANTA, Dec. 26, 2022 /PRNewswire/ — Lipogems, a clinical stage- global medical technology company that utilizes autologous adipose tissue for therapeutic use in…
Read More » -
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
Biologics
Lipogems Provides Orthopaedic Patients With Another Option To Major Invasive Surgery
ATLANTA, Jan. 14, 2019 /PRNewswire/ — The Lipogems system is leading the way in reparative medicine by providing patients another option to major,…
Read More » -
Hospitals
FDA Clears The Way: Lipogems’ Receives FDA Clearance For Microfragmented Adipose Tissue System Utilizing Body’s Own Fat To Support Tissue Repair In Orthopaedic And Arthroscopic Surgeries
NORCROSS, Ga., July 5, 2018 /PRNewswire/ — Lipogems, a leader in medical technologies for orthopaedic physicians, announced U.S. Food and Drug Administration (FDA)…
Read More »